Cumberland Pharmaceuticals Inc
CPIX
|
|
| |
|
| Trading Volume | 151 |
|
|
2.30 - 1.31 |
| Market Cap Full | $ 19.7M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -6.2% | 8.1% | -13.3% | -39.6% |
| Q2 | - | -11.7% | -24.6% | -26.2% |
| Q3 | - | -3.5% | 28.6% | 15.9% |
| Q4 | - | 101.7% | -2.3% | -6.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 19.5 | 2.4 | -11.7 | -14.4 | -7.5 | -3.4 | -0.7 | -3.5 | - | - | - | 90.6 |
| 2023 | |||||||||||
| 20 | -15.6 | -14.5 | -12.3 | -5.9 | -8.7 | 3.4 | 8.6 | 14.6 | - | -11.1 | 3.6 |
| 2022 | |||||||||||
| -28.1 | -4.5 | -12.2 | -16.7 | -11.1 | -0.5 | 8.2 | 4.4 | 2.6 | 2.1 | -7.7 | -0.9 |
| 2021 | |||||||||||
| 7.8 | 6.9 | -10.6 | -11.9 | 11.1 | -3.9 | 14 | -11.4 | -6.6 | - | 87 | -7.2 |
| 2020 | |||||||||||
| -4.3 | -21.3 | -5.1 | 9.1 | -16.4 | 0.6 | - | -3.3 | -0.3 | -8.1 | 0.3 | -0.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0 | -0.1 | 0 | -0.1 |
| Q2 | 0.1 | -0.1 | 0.1 | -0.1 |
| Q3 | -0.1 | -0 | -0.1 | -0 |
| Q4 | 0 | -0.2 | -0.3 | -0.1 |
| A | -1.3877787807814E-17 | -0.4 | -0.2 | -0.2 |